CCBR Clinical Research

Bucharest, Bucharest 30463

0 studies enrolling now · 3 studies all time

What they study most

Rheumatoid Arthritis, Ulcerative Colitis

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed